{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:33:08Z","timestamp":1780500788167,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.4158\/ep10298.cr","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T11:20:09Z","timestamp":1295436009000},"page":"e32-e36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Panhypopituitarism secondary to a macroprolactinoma manifesting with pancytopenia:case report and literature review"],"prefix":"10.1016","volume":"17","author":[{"given":"George I.","family":"Holmes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP10298.CR_bb0010","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/BF03347241","article-title":"Hypopituitarism and anemia: effect of replacement therapy with hydrocortisone and\/or levothyroxine","volume":"28","author":"Nishioka","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP10298.CR_bb0015","series-title":"Williams Hematology.","first-page":"407","article-title":"Anemia of endocrine disorders","author":"Erslev","year":"2001"},{"key":"10.4158\/EP10298.CR_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.2.4566.75","article-title":"Aplastic anaemia in Simmonds's disease: report of a case","volume":"2","author":"Bloom","year":"1948","journal-title":"Br Med J"},{"key":"10.4158\/EP10298.CR_bb0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2141.1976.tb03576.x","article-title":"Sheehan's syndrome with complete bone marrow aplasia: long-term results of substitution therapy with hormones","volume":"33","author":"Ferrari","year":"1976","journal-title":"Br J Haematol"},{"key":"10.4158\/EP10298.CR_bb0030","first-page":"595","article-title":"A case of pancytopenia caused by Sheehan's syndrome improved with hormone replacement therapy","volume":"15","author":"Kim","year":"2000","journal-title":"J Korean Soc Endocrinol"},{"key":"10.4158\/EP10298.CR_bb0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00277-003-0800-4","article-title":"Case of complete recovery of pancytopenia after treatment of hypopituitarism","volume":"83","author":"Kim","year":"2004","journal-title":"Ann Hematol"},{"key":"10.4158\/EP10298.CR_bb0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1368-5031.2004.00059.x","article-title":"Sheehan's syndrome associated with pancytopenia due to marrow aplasia: full recovery with hormone replacement therapy","volume":"58","author":"Ozdogan","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.4158\/EP10298.CR_bb0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00277-006-0233-y","article-title":"An unusual case of pancytopenia associated with Sheehan's syndrome","volume":"86","author":"Gokmen Akoz","year":"2007","journal-title":"Ann Hematol"},{"key":"10.4158\/EP10298.CR_bb0050","first-page":"P151","article-title":"Two unusual cases of pancytopenia associated with Sheehan's syndrome","volume":"16","author":"Atmaca","year":"2008","journal-title":"Endocrine Abstracts"},{"key":"10.4158\/EP10298.CR_bb0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00277-009-0804-9","article-title":"Sheehan's syndrome with pancytopenia\u2014complete recovery after hormone replacement (case series with review)","volume":"89","author":"Laway","year":"2010","journal-title":"Ann Hematol"},{"key":"10.4158\/EP10298.CR_bb0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4158\/EP.14.2.229","article-title":"Bone marrow hypoplasia responsive to testosterone therapy in a patient with panhypopituitarism: need for adherence to androgen replacement","volume":"14","author":"Badawi","year":"2008","journal-title":"Endocr Pract"},{"key":"10.4158\/EP10298.CR_bb0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000205075","article-title":"A case of pancytopenia in hypopituitarism: with a review of the hematological changes in clinical and experimental pituitary insufficiency","volume":"15","author":"Killmann","year":"1956","journal-title":"Acta Haematol"},{"key":"10.4158\/EP10298.CR_bb0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/003693309804300509","article-title":"Hypoplastic anaemia complicating myxoedema coma","volume":"43","author":"Song","year":"1998","journal-title":"Scot Med J"},{"key":"10.4158\/EP10298.CR_bb0075","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP10298.CR_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1752-1947-4-33","article-title":"Prolactinoma presenting as chronic anaemia with osteoporosis: a case report","volume":"4","author":"MacLean","year":"2010","journal-title":"J Med Case Reports"},{"key":"10.4158\/EP10298.CR_bb0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0889-8529(05)70058-X","article-title":"Differential diagnosis of sellar masses","volume":"28","author":"Freda","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP10298.CR_bb0090","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1182\/blood.V45.5.665.665","article-title":"Effects of testosterone and erythropoietin on erythroid colony formation in human bone marrow cultures","volume":"45","author":"Moriyama","year":"1975","journal-title":"Blood"},{"key":"10.4158\/EP10298.CR_bb0095","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/272260a0","article-title":"Potentiation of human erythropoiesis in vitro by thyroid hormone","volume":"272","author":"Dainiak","year":"1978","journal-title":"Nature"},{"key":"10.4158\/EP10298.CR_bb0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2141.1988.tb02480.x","article-title":"Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin-like growth factor I","volume":"70","author":"Merchav","year":"1988","journal-title":"Br J Haematol"},{"key":"10.4158\/EP10298.CR_bb0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2141.1989.tb06302.x","article-title":"Pituitary dependence of bone marrow function","volume":"71","author":"Nagy","year":"1989","journal-title":"Br J Haematol"},{"key":"10.4158\/EP10298.CR_bb0110","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1191\/096120301717164930","article-title":"Effects of prolactin on hematopoiesis","volume":"10","author":"Welniak","year":"2001","journal-title":"Lupus"},{"key":"10.4158\/EP10298.CR_bb0115","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0301-472X(99)00019-3","article-title":"Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine","volume":"27","author":"Woody","year":"1999","journal-title":"Exp Hematol"},{"key":"10.4158\/EP10298.CR_bb0120","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1093\/emboj\/16.23.6926","article-title":"Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene","volume":"16","author":"Horseman","year":"1997","journal-title":"EMBO J"},{"key":"10.4158\/EP10298.CR_bb0125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/j.1552-4604.1974.tb02316.x","article-title":"Effect of the anabolic protein hormone prolactin on human erythropoiesis","volume":"14","author":"Jepson","year":"1974","journal-title":"J Clin Pharmacol"},{"key":"10.4158\/EP10298.CR_bb0130","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood.V100.8.2687","article-title":"Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis","volume":"100","author":"Abkowitz","year":"2002","journal-title":"Blood"},{"key":"10.4158\/EP10298.CR_bb0135","first-page":"367","article-title":"Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients","volume":"223","author":"Bellone","year":"2000","journal-title":"Proc Soc Exp Biol Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20422724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20422724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/C670315030N417T3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:52:54Z","timestamp":1761515574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20422724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1530891X20422724"],"URL":"https:\/\/doi.org\/10.4158\/ep10298.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Panhypopituitarism secondary to a macroprolactinoma manifesting with pancytopenia:case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP10298.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}